Agenus

- NASDAQ:AGEN
Last Updated 2021-07-23
  • Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.
  • Locations

    • Charlottesville VA
    • Lexington MA
  • Total Funding (USD)

    271.1 million
  • Industries

    Mobile Apps
  • Acquisitions (2)

    • PhosImmune (2015)
    • 4-Antibody AG (2014)
  • Security

    Type: ORD
    CUSIP: 00847G705
    ISIN: US00847G7051
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.